Stroke and Tocotrienol: Unique Role in Neuroprotection
A phase 3 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.
Also called NCT02263924
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 150 participants
- Sponsor
- Registry
-
NCT02263924
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Malaysia
- Registry status
- Unknown status
Technical summary
Registry record NCT02263924. Randomized; quadruple masking; primary purpose treatment. Start 2015-07 (registry gives no type); primary completion 2018-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Stroke and Tocotrienol: Unique Role in Neuroprotection
- Acronym
- SATURN
- Condition
- Ischemic Stroke
- Intervention (Dietary supplement)
- Tocotrienol
- Intervention (Dietary supplement)
- Placebo capsules
- Lead sponsor
- Seberang Jaya Clinical Research Centre
- Collaborator
- Clinical Research Centre Hospital Taiping
- Collaborator
- Universiti Sains Malaysia
Record details
- Record id
cardio:ct-nct02263924- Content hash
e4730f6cb1d54947d921a92ca020b607a9b10d86a1e42eb1f5616c3b59afe19e